CQ Politics reports that health care related PACs accounted for the top or second highest source of contributions for 15 of the top 18 congressional leaders in the House involved in the health care debate.
Apparently, the $80 billion cost savings that the pharmaceutical industry agreed to with the Obama administration came with a price. In return, the White House promised to protect the industry from further attempts to extract cost savings from them including allowing the government to negotiate drug prices. Now we know what those trips to the White House were all about.
The House Selecte Committee on Energy Independence and Global Warming is investigating the forged letters sent to three congressmen by a grassroots lobbying firm on behalf of the American Coalition for Clean Coal Electricity (ACCCE). ACCCE has been trying to distance themselves from Bonner & Associates, the firm in question, and has denounced the letters. In a new letter sent by Chair Ed Markey, ACCCE is questioned as to why they did not act on the forged letters after they discovered their existence on June 24, two days prior to the vote on the cap and trade bill.
A new hire by the State Department may exploit a loophole in the administration’s lobbying ban.
The Washington Post has a useful interactive graphic to compare the various versions of health care reform in Congress.